Association Between Level of Platelet Inhibition After Early Use of Abciximab and Myocardial Reperfusion in ST-Elevation Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
- 1 March 2006
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (6) , 798-803
- https://doi.org/10.1016/j.amjcard.2005.10.019
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Early vs Late Administration of Glycoprotein IIb/IIIa Inhibitors in Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial InfarctionJAMA, 2004
- Abciximab-Supported Infarct Artery Stent Implantation for Acute Myocardial Infarction and Long-Term SurvivalCirculation, 2004
- Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplastyEuropean Heart Journal, 2003
- Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial InfarctionNew England Journal of Medicine, 2002
- Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial InfarctionNew England Journal of Medicine, 2001
- Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary InterventionCirculation, 2001
- Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial InfarctionCirculation, 2001
- Effect of Glycoprotein IIb/IIIa Receptor Blockade on Recovery of Coronary Flow and Left Ventricular Function After the Placement of Coronary-Artery Stents in Acute Myocardial InfarctionCirculation, 1998
- Comparison of Primary Coronary Angioplasty and Intravenous Thrombolytic Therapy for Acute Myocardial InfarctionJAMA, 1997
- Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.Circulation, 1994